# Review Round 4

## 1. Overall Assessment

**Recommendation: Accept / very minor editorial revision**  
**Score: 8/10**

Revision 3 has moved the manuscript from a borderline methods demonstration into a credible simulation-benchmarked computational biology paper. The new sensitivity analyses address the largest remaining methodological gap from Round 3: whether the recovered hallmark network is merely an artifact of shared genes, the ssGSEA scoring choice, or tissue composition. The results are reassuring for two of those concerns: removing the 16 multi-hallmark genes leaves the correlation structure highly similar to the primary analysis (`r = 0.946`), mean z-score scoring closely matches ssGSEA (`r = 0.948`), and tissue regression has essentially no effect (`r = 0.999`). The PCA sensitivity result is also useful because it is negative: pathway PCA produces a fundamentally different correlation structure (`r = -0.027` vs ssGSEA), which correctly cautions that pathway scoring is not a neutral implementation detail.

The manuscript is now appropriately framed as a simulation-first benchmark and software/methods framework, not as an empirical discovery paper about aging biology. It reports mixed benchmark performance honestly: moderate edge recovery, modest centrality recovery, failed module recovery, low edge stability, weak age-effect recovery, and no FDR-significant age-dependent rewiring. The Round 3 contradictions around rewiring have largely been fixed, and the new sensitivity figures/tables make the work more defensible.

I would now consider the paper publishable in an appropriate methods, benchmark, or computational biology software venue, provided the authors make a small editorial cleanup to remove a few remaining overstatements and stale future-work language.

## 2. What Improved Since Round 3?

1. **The missing sensitivity analyses were added and are quantitatively useful.**  
   The manuscript now includes three targeted checks that directly address prior reviewer concerns:
   - Shared-gene removal: original vs shared-gene-removed correlation matrix similarity `r = 0.946`.
   - Scoring method comparison: ssGSEA vs mean z-score `r = 0.948`, but ssGSEA vs pathway PCA `r = -0.027`.
   - Tissue-covariate adjustment: unadjusted vs tissue-regressed correlation matrix similarity `r = 0.999`.

2. **The shared-gene concern is no longer a major weakness.**  
   Earlier versions left open the possibility that the hallmark interaction network was driven by genes assigned to multiple hallmarks. The new removal analysis substantially reduces that concern. It does not prove the correlations are biological in real data, but it shows the simulated network is not simply a gene-overlap artifact.

3. **The scoring-method comparison is more nuanced than a robustness-only result.**  
   The ssGSEA and mean z-score agreement supports robustness to two simple activity summaries. The PCA divergence is important because it shows that score definition can materially alter downstream network topology. This is the right kind of sensitivity result: it both supports the primary analysis and defines its boundary.

4. **Tissue confounding is now directly assessed.**  
   The OLS tissue-residualization result (`r = 0.999`) demonstrates that the primary hallmark network is not materially changed by tissue covariates in this simulation. This was an important missing control in a multi-tissue dataset.

5. **The Round 3 rewiring contradiction has been fixed.**  
   The Results, Discussion, and Conclusions now consistently state that no hallmark pairs survived FDR correction. This resolves the most important remaining Round 3 defect.

6. **Hub and module language is more cautious than before.**  
   The text now acknowledges that hub identification is noisy and that benchmarked centrality recovery is only moderate (`rho = 0.45`, top-3 overlap = 33%). The manuscript also foregrounds failed module recovery (ARI = -0.052), which keeps the two-module finding from being presented as a validated biological discovery.

7. **The manuscript now has a coherent benchmark narrative.**  
   The sensitivity analyses, benchmark table, and negative age-rewiring result all point in the same direction: the pipeline can recover some edge-level structure under controlled simulation, but higher-order network properties and age-dependent rewiring are fragile.

## 3. Remaining Issues

### Minor Issues

1. **The module conclusion is still too strong relative to the benchmark.**  
   The Results and Discussion still describe a two-module architecture as a meaningful "damage-accumulation" versus "tissue-decline" organization. This is acceptable as a description of the primary inferred network, but the wording sometimes reads as if the module structure itself was validated. It was not: module ARI is `-0.052`, indicating failed recovery of the embedded three-tier hierarchy. The authors should explicitly qualify the two-module interpretation as an observed partition in the inferred network, not a robustly recovered or biologically validated architecture.

2. **The hub conclusion remains slightly overinterpreted.**  
   The paper now acknowledges noisy hub recovery, but phrases such as "SCE as the principal hub hallmark" and "integrative hallmarks serve as convergence points" still risk sounding definitive. Given centrality `rho = 0.45`, `p = 0.22`, top-3 hub overlap = 33%, and low edge stability, this should be softened to "ranked highest in this inferred network" rather than treated as a reliable biological or methodological finding.

3. **The limitations/future-work section contains stale language.**  
   The Limitations still says "Shared genes between hallmarks may induce artificial cross-hallmark correlation; sensitivity analysis removing shared genes is warranted." That analysis has now been performed. This should be updated to say that the new shared-gene removal analysis was reassuring in this simulation, while broader gene-set curation uncertainty remains.

4. **The future-work list should distinguish completed sensitivity checks from remaining ones.**  
   It still lists "compare scoring methods systematically" and "perform sensitivity analyses on gene-set composition and shared-gene effects." Some of this has now been done. A better wording would be: extend scoring comparisons to GSVA, singscore, PLAGE, and direction-aware signatures; expand gene-set perturbation analyses beyond removal of the 16 shared genes.

5. **The biological-age section still uses "significantly" without visible statistical support.**  
   The Discussion says all ML models "significantly outperformed" baseline predictors. Unless the manuscript reports paired tests or confidence intervals for the baseline comparisons, "significantly" should be removed or replaced with "outperformed in cross-validation."

6. **Some figure/caption wording still implies more than the statistical evidence supports.**  
   The biological-age figure caption uses "biological age acceleration" language even though the Results correctly warn that simulated residuals should not be interpreted that way. The cross-hallmark prediction caption says higher `R^2` indicates "greater determination by the hallmark network"; "greater predictability from other hallmark scores" would be more accurate.

7. **The PC-algorithm figure filename and label still use causal terminology internally.**  
   The visible caption is now appropriately cautious, but the file remains `fig11_causal_network.pdf` and the label remains `fig:causal`. This is not a scientific blocker if the rendered text is careful, but renaming would improve consistency.

### Not Blocking, But Important for Future Work

1. **No real-data validation remains the main ceiling on venue impact.**  
   This is acceptable for a simulation benchmark, but it prevents the paper from supporting biological claims about aging hallmark interactions in real tissues.

2. **The benchmark is still based on one simulation family.**  
   The authors benchmark against known embedded structure, which is a strength. But the conclusions would be stronger with multiple simulation regimes varying noise, gene-set overlap, tissue effects, nonlinear age trends, cell-type mixture, and sample size.

3. **The scoring comparison is incomplete but no longer absent.**  
   The current ssGSEA/mean-z/PCA comparison is useful. For a full methodological benchmark, GSVA, singscore, PLAGE, AUCell, and direction-aware gene-set scoring would be natural extensions.

## 4. Trajectory Assessment: Rounds 1 -> 2 -> 3 -> 4

The trajectory is strongly positive and unusually clear.

**Round 1: 2/10, Reject.**  
The original version was not publishable. It presented simulated results too much like empirical biological discovery, made unsupported causal claims, used weak or optimistic statistical framing, and lacked serious ground-truth benchmarking.

**Round 2: 5/10, Major Revision.**  
The authors made the essential conceptual shift by reframing the work as a simulation-benchmarked framework and adding benchmark metrics. However, the manuscript still contained stale numbers, placeholder benchmark entries, overclaiming of weak performance, and contradictions around FDR-corrected age rewiring.

**Round 3: 7/10, Minor Revision.**  
The manuscript became internally coherent in its main numerical results. It correctly reported mixed benchmark performance and acknowledged no FDR-significant rewiring. Remaining problems were mostly localized: stale Discussion claims, overstrong hub/module language, and missing sensitivity analyses.

**Round 4: 8/10, Accept / very minor editorial revision.**  
The new sensitivity analyses resolve the major remaining methodological concern. The paper now has a defensible identity: an open, simulation-benchmarked framework that shows moderate edge recovery but limited reliability for modules, hubs, and age-dependent rewiring. The remaining issues are mostly wording and scope management, not fundamental validity problems.

## 5. Verdict: Is This Now Publishable?

**Yes, for the right venue and framing.**

I would support publication as a **methods demonstration, simulation benchmark, software/resource note, or computational biology workflow paper**. The paper's contribution is not a new biological map of aging hallmark interactions. Its contribution is a reproducible framework plus an unusually transparent benchmark showing what can and cannot be recovered from hallmark-level transcriptomic scores under controlled conditions.

Appropriate venues would include methods-oriented computational biology journals, software/resource tracks, workshop proceedings, or aging-focused computational venues that accept simulation-first validation. It may also fit a journal interested in reproducible bioinformatics workflows, provided the claims remain clearly methodological.

I would not position it as a high-impact biological discovery paper unless the authors add real multi-tissue transcriptomic validation, ideally with GTEx or Aging Atlas data, stronger covariate handling, external replication, and more comprehensive scoring-method comparisons.

**Final recommendation:** Accept after very minor editorial revision. The requested Round 3 fixes were substantially addressed, and the remaining concerns can be handled with wording changes rather than new analyses.
